Lord Bassam of Brighton

To ask Her Majesty's Government what assessment they have made of the impact on supplies of COVID-19 vaccines to the UK in the event of the UK's departure from the EU without a deal.

To ask Her Majesty's Government what proportion of (1) syringes, (2) vials, and (3) other medical equipment required for a national COVID-19 vaccination programme they have (a) purchased, and (b) ordered.

To ask Her Majesty's Government how many staff from (1) Deloitte, (2) the Boston Consulting Group, and (3) McKinsey, are currently employed within their COVID-19 testing system; and what experience in laboratory-based testing is required in order to be el...

To ask Her Majesty's Government how many applications for licences for military exports (1) to Saudi Arabia, (2) to UAE, (3) to Bahrain, (4) to Kuwait, and (5) to Egypt, they have approved since 7 July.

To ask Her Majesty's Government what assessment they have made of the capability of UK regulators (1) to maintain existing statutory protections relating to harmful online content, and (2) to ensure effective enforcement of these protections, between the ...

To ask Her Majesty's Government what assessment they have made of (1) any governance and regulatory gaps in online harms protections that will emerge at the end of the transition period for the UK’s departure from the EU, and (2) the risks to young people...

To ask Her Majesty's Government what steps they have taken in the last three months to progress their proposed online harms legislation; and whether such legislation will be subject to pre-legislative scrutiny.

To ask Her Majesty's Government what contingency plans they have made to alter a COVID-19 vaccination schedule if a booster dose is required.

To ask Her Majesty's Government, further to the Written Answer by Lord Bethell (HL5829) on 21 October, what was the cost of using laboratory facilities in the USA for processing the 66,648 tests; which company or companies were used in sending those tests...

To ask Her Majesty's Government, further to the Written Answer by Lord Bethell on 20 July (HL5350), how many COVID-19 tests have been sent by post and subsequently returned to laboratories, for each day since the scheme began; and how many of the tests se...

To ask Her Majesty's Government what infrastructure they have place to ensure RNA-based COVID-19 vaccines could remain frozen throughout the supply chain.

To ask Her Majesty's Government what information on local support systems is provided to individuals traced through the NHS COVID-19 test, track and trace system to help them to isolate.

To ask Her Majesty's Government, further to the Written Answer by Lord Bethell on 20 July (HL6147), whether they will publish the data on how many people (1) received test results within 24 hours, (2) who tested positive were reached within 24 hours for n...

To ask Her Majesty's Government how many civil servants (1) were staffing, (2) joined, and (3) left, their COVID-19 testing programme in each calendar month from March to October.

To ask Her Majesty's Government how many COVID-19 tests that have been sent through the post were (1) analysed in UK laboratories, and (2) sent overseas for analysis, in May.

To ask Her Majesty's Government what additional buildings and facilities on the Royal Sussex County hospital site will be covered by the Prime Minister's announcement on 11 August of £300 million being made available to NHS trusts to upgrade accident and ...

To ask Her Majesty's Government when they plan to hold a formal consultation on the UK Shared Prosperity Fund; and whether any such consultation will include a framework for the Fund to ensure that it is accountable and transparent in its distribution pri...

To ask Her Majesty's Government what is the timetable for the introduction of the UK Shared Prosperity Fund.

To ask Her Majesty's Government what progress they have made towards establishing the UK Shared Prosperity Fund.

To ask Her Majesty's Government what guidance they have made available relating to the management of student shared accommodation in areas (1) where there is a high prevalence of COVID-19, and (2) in local lockdown.